Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 9Neoplastic Cells, Circulating 7Lung Neoplasms 7Leukemia 7Rectal Neoplasms 6Colorectal Neoplasms 6Colonic Neoplasms 6Prostatic Neoplasms 5Leukemia, Myeloid, Acute 5Carcinoma, Non-Small-Cell Lung 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Multiple Myeloma 3Kidney Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Renal Cell 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Neoplasms, Plasma Cell 2Melanoma 2Esophageal Neoplasms 2Congenital Abnormalities 2Carcinoma, Ovarian Epithelial 2Carcinoma, Intraductal, Noninfiltrating 2Breast Neoplasms, Male 2Adenocarcinoma Of Esophagus 2Waldenstrom Macroglobulinemia 1Unspecified Adult Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Salivary Gland Neoplasms 1Pancreatic Neoplasms 1

Interventions

Radiotherapy 8Doxorubicin 7pazopanib 5palbociclib 4Trabectedin 4Gemcitabine 4ribociclib 3pembrolizumab 3eribulin 3selinexor 2liposomal doxorubicin 2avelumab 2Sunitinib 2Radiation Dose Hypofractionation 2Magnetic Resonance Spectroscopy 2Immunoglobulin G 2Ifosfamide 2Docetaxel 23-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2zimberelimab 1temsirolimus 1sotigalimab 1sodium thiosulfate 1sitravatinib 1silmitasertib 1sargramostim 1romidepsin 1regorafenib 1plitidepsin 1pemigatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Liposarcoma × Reverse Transcriptase Polymerase Chain Reaction × Clear all
NCT00233948 2015-04-01

Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma

City of Hope Medical Center

Phase 1/2 Terminated
29 enrolled 7 charts
Sarcoma

Liposarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡